Adriann Sax

Adriann Sax

Verkställande Direktör på
Vetigenics LLC
65 år
Health Technology
Consumer Services
Commercial Services

Profil

Adriann W.
Sax
is the founder of Vetigenics LLC, serving as President, Chief Executive Officer & Director since 2017.
Former positions include Chief Executive Officer & Director at Orsenix LLC from 2019 to 2020, Executive Director-Oncology at Merck & Co., Inc., Director at Healthcare Businesswomen Association, Independent Director at QSAM Biosciences, Inc. from 2022 to 2024, Vice President-Marketing at Bristol Myers Squibb Co., EVP-Business Development & Strategic Planning at KP Pharmaceuticals LLC, Principal at Sterling Drug, Inc., Chief Business Officer at Symphogen A, Principal at Roche Laboratories, Inc., and Chief Commercial Officer & Executive VP at Kadmon Corp.
LLC.
Education includes an undergraduate degree from the University of Delaware and an MBA from Keller Graduate School of Management.

Aktiva positioner av Adriann Sax

FöretagPositionStart
Verkställande Direktör 2017-01-01

Tidigare kända positioner av Adriann Sax

FöretagPositionSlut
Direktör/Styrelseledamot 2024-05-02
Verkställande Direktör 2020-01-01
Företagsledare/Principal -
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Adriann Saxs erfarenhet

Adriann Saxs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

9

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Non-Durables

Consumer Services

Health Technology

Distribution Services

Consumer Services

Health Technology

Process Industries

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Adriann Sax